CRP and cancer: Clinically meaningful alleviation of CRP can be achieved through opioid use in approximately 80% cases [20], and while multimodal management strategies are needed for the remaining approximately 20% of cases [21], opioid therapies are an indispensable resource for pain and symptom management among patients with cancer.